Company CVAbout Syncom Formulations (India) Ltd 
Syncom Formulations (India) Ltd
Small Cap
Pharmaceuticals & Drugs
Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
Company Coordinates
Company Details
7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd Mumbai Maharashtra : 400093
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore
Capital StructureCapital Structure
Present Equity Capital
INR 94.00 Cr
Number of Shares
94 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-May-2022
94
94.00
77547000
1
Conversion of Warrants
25-Feb-2022
86.25
86.25
32500000
1
Conversion of Warrants
27-Aug-2021
83
83.00
40000820
1
Conversion of Warrants
27-Mar-2021
79
79.00
9300000
1
Conversion of Warrants
19-Aug-2013
22.3
22.30
200739132
1
Stock Split
19-Aug-2013
78.07
78.07
557608700
1
Bonus
19-Aug-2013
22.3
22.30
200739132
1
Stock Split
19-Aug-2013
78.07
78.07
557608700
1
Bonus
25-Feb-2011
2.23
22.30
3870000
10
Conversion of Warrants
25-Feb-2011
2.23
22.30
3870000
10
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 2 Schemes (0.0%)
FIIs
Held by 7 FIIs (0.13%)
Promoter with highest holding
Kedarmal Shankarlal Bankda (12.44%)
Highest Public shareholder
None
Individual Investors Holdings
45.06%
Board of Directors
Management
Designation
Remuneration
Kedarmal Bankda
Chairman & Wholetime Director
70.99 lacs
Vijay Shankarlal Bankda
Managing Director
53.99 lacs
Vinod Kumar Kabra
Independent Director
25.0 k
Krishna Das Neema
Independent Director
25.0 k
Praveen Jindal
Independent Director
15.0 k
Rinki Bankda
Whole-time Director
28.8 lacs
Ruchi Jindal
Independent Director
5.0 k
Vaishali Agrawal
Company Sec. & Compli. Officer
0
Ritesh Kumar Lunkad
Independent Director
0
Ankit Jain
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Agro Commodity Purchased
36.9395
0%
Agro Commodity Purchased
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Dry Powder - Traded
0.95
0.51%
Dry Powder - Traded
Dry Powder - Traded
Stock DNARevenue and Profits:
Net Sales:
128 Cr
(Quarterly Results - Dec 2024)
Net Profit:
13 Cr
Pharmaceuticals & Drugs
INR 1,584 Cr (Small Cap)
39.00
33
0.00%
-0.21
11.51%
5.33
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
